share_log

Mineralys Therapeutics Q4 EPS $(0.61) Beats $(0.82) Estimate

Mineralys Therapeutics Q4 EPS $(0.61) Beats $(0.82) Estimate

Mineralys Therapeutics第四季度每股收益美元(0.61美元)超過預期(0.82美元)
Moomoo 24/7 ·  03/21 07:03

Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.82) by 25.61 percent. This is a 64.94 percent increase over losses of $(1.74) per share from the same period last year.

Mineralys Therapeutics(納斯達克股票代碼:MLYS)公佈的季度虧損爲每股0.61美元,比分析師共識估計的美元(0.82美元)高出25.61%。這比去年同期每股虧損1.74美元(1.74美元)增長了64.94%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論